JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.77% |
| 2 | Technology | 12.5% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
CALL
Applied Materials
AMAT
$424B
| $890K | ﹤0.01% |
16,000
-155,000
| -91% | -$8.63M |
|
3552
State Street SPDR S&P Software & Services ETF
XSW
$515M
| $890K | ﹤0.01% |
11,770
+2,699
| +30% | +$202K |
|
3553
TETRA Technologies
TTI
$1.25B
| $887K | ﹤0.01% |
236,649
-125,215
| -35% | -$492K |
|
3554
PetMed Express
PETS
$43.4M
| $884K | ﹤0.01% |
21,166
-80,553
| -79% | -$3.72M |
|
3555
Riverview Bancorp
RVSB
$107M
| $882K | ﹤0.01% |
94,405
+9,251
| +11% | +$84.2K |
|
|
HTB
3556
HomeTrust Bancshares
HTB
$837M
| $882K | ﹤0.01% |
33,858
-3,140
| -8% | -$82.1K |
|
3557
James River Group Holdings
JRVR
$200M
| $880K | ﹤0.01% |
24,806
-9,933
| -29% | -$361K |
|
|
OSG
3558
Octave Specialty Group
OSG
$212M
| $876K | ﹤0.01% |
55,836
+2,830
| +5% | +$43.8K |
|
|
CBIO
3559
CALL
Crescent Biopharma
CBIO
$618M
| $876K | ﹤0.01% |
540
-270
| -33% | -$562K |
|
|
CBIO
3560
PUT
Crescent Biopharma
CBIO
$618M
| $876K | ﹤0.01% |
540
-270
| -33% | -$562K |
|
3561
Cal-Maine
CALM
$3.87B
| $875K | ﹤0.01% |
20,023
+10,870
| +119% | +$471K |
|
3562
Yatra Online
YTRA
$55.3M
| $875K | ﹤0.01% |
132,409
+117,208
| +771% | +$825K |
|
3563
El Pollo Loco
LOCO
$471M
| $872K | ﹤0.01% |
91,764
+48,752
| +113% | +$483K |
|
|
SIGM
3564
DELISTED
Sigma Designs Inc
SIGM
| $872K | ﹤0.01% |
140,630
-27,702
| -16% | -$172K |
|
3565
Integra LifeSciences
IART
$1.42B
| $871K | ﹤0.01% |
15,751
-29,470
| -65% | -$1.54M |
|
3566
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
| $868K | ﹤0.01% |
25,890
+13,171
| +104% | +$444K |
|
3567
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46.1B
| $868K | ﹤0.01% |
17,073
+3,598
| +27% | +$183K |
|
|
XOXO
3568
DELISTED
Xo Group Inc
XOXO
| $868K | ﹤0.01% |
41,793
-1,802
| -4% | -$35.7K |
|
3569
WisdomTree Enhanced Commodity Strategy Fund
GCC
$280M
| $866K | ﹤0.01% |
45,002
+39,586
| +731% | +$768K |
|
3570
Lindsay Corp
LNN
$1.17B
| $865K | ﹤0.01% |
9,460
-26,329
| -74% | -$2.39M |
|
3571
Genie Energy
GNE
$386M
| $864K | ﹤0.01% |
173,117
-15,103
| -8% | -$68.9K |
|
3572
State Street SPDR S&P Insurance ETF
KIE
$681M
| $862K | ﹤0.01% |
27,779
+7,671
| +38% | +$238K |
|
|
WW
3573
DELISTED
WW International
WW
| $860K | ﹤0.01% |
13,515
-150,662
| -92% | -$9.66M |
|
|
NBIS
3574
CALL
Nebius Group N.V.
NBIS
$69.3B
| $860K | ﹤0.01% |
21,800
-478,200
| -96% | -$18.8M |
|
3575
Lexicon Pharmaceuticals
LXRX
$1.04B
| $859K | ﹤0.01% |
100,309
-8,517
| -8% | -$78.8K |
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,570 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.